Add BrightSurf on Google Email

University of California - San Francisco


Hepatitis C drug overwhelms virus with flood of mutations - surprising mechanism may improve anti-viral treatments, UCSF study finds

A recent study from the University of California, San Francisco has discovered a novel mechanism by which the drug ribavirin kills viruses by generating excess mutations that overwhelm the virus. This unexpected finding may lead to the development of more effective anti-viral treatments for hepatitis C patients.

SourceUniversity of California - San Francisco·JournalNature Medicine·DateDec 7, 2000

Researchers reveal insidious role of a 'serpin' in Alzheimer's Disease

A team of researchers found that the protein alpha1-antichymotrypsin doubles the accumulation of Alzheimer's disease-associated amyloid plaque in mice brains, indicating a potential therapeutic target. The study suggests that reducing or inhibiting this protein's activity could help prevent plaque formation and brain damage.

SourceUniversity of California - San Francisco·JournalAmerican Journal Of Pathology·DateDec 4, 2000

Mammography no more sensitive in women with family history of breast cancer, says UCSF/SFVAMC study

A new study by UCSF/SFVAMC researchers found that mammography is equally effective in detecting breast cancer in women with and without a family history. The study analyzed data from over 389,000 women and showed that mammography detects nearly 85% of cancers in women aged 50-69, regardless of family history.

SourceUniversity of California - San Francisco·JournalAnnals of Internal Medicine·DateDec 3, 2000

Finding could lead to new approach for treating severe heart disease

A new study by UCSF researchers found that delivering the VEGF growth factor into mice with coronary heart disease prompted the growth of blood vessels in damaged heart tissue without causing side effects. This approach could lead to a treatment strategy for severe coronary heart disease that has been met with setbacks.

SourceUniversity of California - San Francisco·JournalProceedings of the National Academy of Sciences·DateDec 3, 2000

Immunotherapy slows disease progression and lowers PSA levels in some men with prostate cancer, UCSF study finds

A novel therapy employing the immune system to attack prostate cancer cells has been found to slow disease progression in some men and decrease PSA levels. The study's results show that modified dendritic cells can train lymphocytes to recognize prostate cancer cells, leading to a stronger immune response.

SourceUniversity of California - San Francisco·JournalJournal of Clinical Oncology·DateNov 30, 2000

UCSF analysis suggests strengthening conflict of interest policies governing clinical trials at nation's major medical research centers

A UCSF study analyzed conflict of interest policies at top US medical schools, finding 'loopholes' in disclosure and conflict management. The researchers suggest prohibiting investigators from holding stock or decision-making positions in companies that may be affected by the trial.

SourceUniversity of California - San Francisco·JournalNew England Journal of Medicine·DateNov 28, 2000

An assessment of yourself as rich and powerful may keep you healthy, according to a UCSF study

A UCSF study found that women who perceived themselves higher on the social ladder reported better physical health, lower stress levels, and less abdominal fat. The researchers suggest that this perception is linked to a lower cortisol response to stress, which can contribute to metabolic and cardiovascular disease.

SourceUniversity of California - San Francisco·JournalHealth Psychology·DateNov 18, 2000

UCSF-Harvard team publishes major HIV therapy study over objections of sponsor; compound shows no effect on slowing disease progression

A large randomized trial evaluating a compound intended to boost the immune response of HIV patients showed no effect on slowing disease progression. The study, led by UCSF and Harvard researchers, defied the sponsor's attempt to block publication, affirming the University's right to publish unfavorable or neutral research findings.

Growing number of financial ties between academic researchers and private industry shows need for strict disclosure and management

A new study by University of California, San Francisco researchers highlights the need for clear guidelines to manage potential conflicts of interest in academic research. The study found that nearly eight percent of UCSF scientists reported financial ties to industry sponsors in 1999, with complex relationships being seen as problematic.

Study finds women screened for cervical cancer one, two and three years after normal test results have same low rate of abnormalities

A US study found that women with recent normal Pap smear results have a similar low rate of significant cellular abnormalities regardless of the time interval between screenings. The study suggests that some women may not need to be screened annually, and that less frequent screening may be safe for low-risk women.

SourceUniversity of California - San Francisco·JournalObstetrics and Gynecology·DateJul 30, 2000

Program that provides family planning services to low income residents helps reduce rate of unintended pregnancies in the state

The California Family PACT program has significantly reduced the number of unintended pregnancies among low-income women in California. The program saved over $512 million in public expenditures by providing comprehensive family planning services to more than 1.5 million clients, including education, counseling, and clinical services.